{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T02:57:28Z","timestamp":1787972248730,"version":"build-2784847793"},"reference-count":193,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.numecd.2025.104215","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T12:02:51Z","timestamp":1751457771000},"page":"104215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Translational biomarkers for integrated cardiovascular disease risk assessment: A multidisciplinary review with applications in precision medicine"],"prefix":"10.1016","volume":"35","author":[{"given":"Francesco","family":"Visioli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego Mart\u00ednez","family":"Urbistondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sokratis","family":"Gkipalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Vidal-Ostos De Lara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ruiz-Saavedra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Beddar Chaib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aitor Hern\u00e1ndez","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel Fort\u00fan","family":"Landecho Acha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mois\u00e9s","family":"Laparra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Vizmanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2505-1555","authenticated-orcid":false,"given":"Omar","family":"Ramos-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Yannakoulia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Alfredo","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2025.104215_bib1","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1016\/j.jacc.2019.10.009","article-title":"The global burden of cardiovascular diseases and risk factors: 2020 and beyond","volume":"74","author":"Mensah","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2025.104215_bib2","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","article-title":"The global burden of cardiovascular diseases and risk: a compass for future health","volume":"80","author":"Vaduganathan","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2025.104215_bib3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12913-015-0772-9","article-title":"Acute and chronic impact of cardiovascular events on health state utilities","volume":"15","author":"Matza","year":"2015","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.numecd.2025.104215_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11789-017-0082-3","article-title":"Prevention of cardiovascular complications in patients with Lp(a)-hyperlipoproteinemia and progressive cardiovascular disease by long-term lipoprotein apheresis according to German national guidelines","volume":"12","author":"Klingel","year":"2017","journal-title":"Clin Res Cardiol Suppl"},{"key":"10.1016\/j.numecd.2025.104215_bib5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3389\/fpubh.2020.00379","article-title":"Use of an exposome approach to understand the effects of exposures from the natural, built, and social environments on cardio-vascular disease onset, progression, and outcomes","volume":"8","author":"Juarez","year":"2020","journal-title":"Front Public Health"},{"key":"10.1016\/j.numecd.2025.104215_bib6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3132\/dvdr.2008.046","article-title":"The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient","volume":"5","author":"Fruchart","year":"2008","journal-title":"Diabetes Vasc Dis Res"},{"key":"10.1016\/j.numecd.2025.104215_bib7","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1186\/1471-2458-11-704","article-title":"Excess risk attributable to traditional cardiovascular risk factors in clinical practice settings across Europe - the EURIKA Study","volume":"11","author":"Guallar","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/j.numecd.2025.104215_bib8","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2025.104215_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014402","article-title":"Incidence and predictors of major adverse cardiovascular events in patients with established atherosclerotic disease or multiple risk factors","volume":"9","author":"Miao","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.numecd.2025.104215_bib10","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1053\/j.jvca.2022.04.040","article-title":"Maternal and fetal outcomes in adult congenital heart disease","volume":"36","author":"Venkataramani","year":"2022","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.numecd.2025.104215_bib11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11883-025-01308-9","article-title":"High density lipoprotein particle composition, functionality, deficiency, and atherosclerotic cardiovascular disease risk: a review","volume":"27","author":"Schaefer","year":"2025","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.numecd.2025.104215_bib12","doi-asserted-by":"crossref","DOI":"10.1172\/JCI148559","article-title":"Addressing dyslipidemic risk beyond LDL-cholesterol","volume":"132","author":"Tall","year":"2022","journal-title":"J Clin Investig"},{"key":"10.1016\/j.numecd.2025.104215_bib13","article-title":"Oxidized low-density lipoprotein associates with cardiovascular disease by a vicious cycle of atherosclerosis and inflammation: a systematic review and meta-analysis","volume":"9","author":"Hong","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.numecd.2025.104215_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/joim.13794","article-title":"Platelets as an inter-player between hyperlipidaemia and atherosclerosis","volume":"296","author":"Li","year":"2024","journal-title":"J Intern Med"},{"key":"10.1016\/j.numecd.2025.104215_bib15","first-page":"1191","article-title":"The exposome and cardiovascular health","volume":"39","author":"Motairek","year":"2023","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.numecd.2025.104215_bib16","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2022.10.031","article-title":"Lysophosphatidylcholines modulate immunoregulatory checkpoints in peripheral monocytes and are associated with mortality in people with acute liver failure","volume":"78","author":"Trovato","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.numecd.2025.104215_bib17","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev-physiol-021909-135846","article-title":"Macrophages, inflammation, and insulin resistance","volume":"72","author":"Olefsky","year":"2010","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.numecd.2025.104215_bib18","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/aje\/kwv325","article-title":"Use of the \"exposome\" in the practice of epidemiology: a primer on -omic technologies","volume":"184","author":"DeBord","year":"2016","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.numecd.2025.104215_bib19","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41569-023-00873-3","article-title":"The contribution of the exposome to the burden of cardiovascular disease","volume":"20","author":"Munzel","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.numecd.2025.104215_bib20","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1021\/acs.estlett.1c00648","article-title":"Defining the scope of exposome studies and research needs from a multidisciplinary perspective","volume":"8","author":"Zhang","year":"2021","journal-title":"Environ Sci Technol Lett"},{"key":"10.1016\/j.numecd.2025.104215_bib21","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1093\/advances\/nmac067","article-title":"Nutri-epigenetic effects of phenolic compounds from extra virgin olive oil: a systematic review","volume":"13","author":"Del Saz-Lara","year":"2022","journal-title":"Adv Nutr"},{"key":"10.1016\/j.numecd.2025.104215_bib22","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2337\/ds17-0045","article-title":"Erratum: multidisciplinary team-based obesity treatment in patients with diabetes: current practices and the state of the science","volume":"30","author":"Foster","year":"2017","journal-title":"Diabetes Spectr"},{"key":"10.1016\/j.numecd.2025.104215_bib23","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2337\/ds17-0045","article-title":"Multidisciplinary team-based obesity treatment in patients with diabetes: current practices and the state of the science","volume":"30","author":"Foster","year":"2017","journal-title":"Diabetes Spectr"},{"issue":"Suppl 3","key":"10.1016\/j.numecd.2025.104215_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP161365.GL","article-title":"American association of clinical endocrinologists and American college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity","volume":"22","author":"Garvey","year":"2016","journal-title":"Endocr Pract"},{"key":"10.1016\/j.numecd.2025.104215_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/science.abe9383","article-title":"Diet-regulated production of PDGFcc by macrophages controls energy storage","volume":"373","author":"Cox","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.numecd.2025.104215_bib26","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2147\/VHRM.S405039","article-title":"The potential of single nucleotide polymorphisms (SNPs) as biomarkers and their association with the increased risk of coronary heart disease: a systematic review","volume":"19","author":"Sitinjak","year":"2023","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.numecd.2025.104215_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22084182","article-title":"Genetics of cardiovascular disease: how far are we from personalized CVD risk prediction and management?","volume":"22","author":"Vrablik","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.numecd.2025.104215_bib28","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1056\/NEJMoa1605086","article-title":"Genetic risk, adherence to a healthy lifestyle, and coronary disease","volume":"375","author":"Khera","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2025.104215_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4103\/HEARTVIEWS.HEARTVIEWS_140_19","article-title":"Genetics in cardiovascular disease","volume":"21","author":"Hajar","year":"2020","journal-title":"Heart Views"},{"key":"10.1016\/j.numecd.2025.104215_bib30","doi-asserted-by":"crossref","first-page":"e685","DOI":"10.1016\/j.jacl.2024.07.001","article-title":"Addressing residual risk beyond statin therapy: new targets in the management of dyslipidaemias-A report from the European Society of Cardiology Cardiovascular Round Table","volume":"18","author":"Mach","year":"2024","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.numecd.2025.104215_bib31","doi-asserted-by":"crossref","first-page":"III15","DOI":"10.1161\/01.CIR.0000131513.33892.5b","article-title":"New risk factors for atherosclerosis and patient risk assessment","volume":"109","author":"Fruchart","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2025.104215_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1264319","article-title":"High residual cardiovascular risk after lipid-lowering: prime time for Predictive, Preventive, Personalized, Participatory, and Psycho-cognitive medicine","volume":"10","author":"Reijnders","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.numecd.2025.104215_bib33","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.jacl.2017.06.015","article-title":"Residual atherosclerotic cardiovascular disease risk in statin-treated adults: the Multi-Ethnic Study of Atherosclerosis","volume":"11","author":"Wong","year":"2017","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.numecd.2025.104215_bib34","article-title":"Residual cardiovascular risk, use of standard care treatments, and achievement of treatment goals in patients with cardiovascular disease","volume":"18","author":"Siniawski","year":"2023","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"key":"10.1016\/j.numecd.2025.104215_bib35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/bmj.38678.389583.7C","article-title":"Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies","volume":"332","author":"Huxley","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.numecd.2025.104215_bib36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/1535370217750088","article-title":"Biomarker definitions and their applications","volume":"243","author":"Califf","year":"2018","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.numecd.2025.104215_bib37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0098-2997(02)00017-1","article-title":"Biomarkers","volume":"23","author":"Griffiths","year":"2002","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.numecd.2025.104215_bib38","article-title":"New biomarkers for cardiovascular disease","volume":"50","author":"Kim","year":"2023","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.numecd.2025.104215_bib39","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/HEARTVIEWS.HEARTVIEWS_106_17","article-title":"Risk factors for coronary artery disease: historical perspectives","volume":"18","author":"Hajar","year":"2017","journal-title":"Heart Views"},{"key":"10.1016\/j.numecd.2025.104215_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12071180","article-title":"Cardiovascular risk prediction models and scores in the era of personalized medicine","volume":"12","author":"Sofogianni","year":"2022","journal-title":"J Pers Med"},{"key":"10.1016\/j.numecd.2025.104215_bib41","first-page":"412","article-title":"Comparison of the Framingham risk and SCORE models in predicting the presence and severity of coronary artery disease considering SYNTAX score","volume":"16","author":"Gunaydin","year":"2016","journal-title":"Anatol J Cardiol"},{"key":"10.1016\/j.numecd.2025.104215_bib42","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fcvm.2019.00091","article-title":"Relevance of multi-omics studies in cardiovascular diseases","volume":"6","author":"Leon-Mimila","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.numecd.2025.104215_bib43","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.1038\/s41467-024-50125-2","article-title":"Plasma metabolomics reveals the shared and distinct metabolic disturbances associated with cardiovascular events in coronary artery disease","volume":"15","author":"Lv","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.numecd.2025.104215_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.887771","article-title":"Different profiles of lipoprotein particles associate various degrees of cardiac involvement in adolescents with morbid obesity","volume":"10","author":"Siurana","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1016\/j.numecd.2025.104215_bib45","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00391-2017","article-title":"What is precision medicine?","volume":"50","author":"Konig","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.numecd.2025.104215_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/cells12222647","article-title":"Cardiovascular biomarkers: current status and future directions","volume":"12","author":"Filipovic","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.numecd.2025.104215_bib47","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.numecd.2025.104215_bib48","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022264","article-title":"Cardiovascular family history increases the risk of disease recurrence after a first myocardial infarction","volume":"10","author":"Wahrenberg","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.numecd.2025.104215_bib49","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1001\/jamacardio.2018.0022","article-title":"Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity","volume":"3","author":"Khan","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.numecd.2025.104215_bib50","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1017\/S0007114521000064","article-title":"Abdominal obesity and risk of CVD: a dose-response meta-analysis of thirty-one prospective studies","volume":"126","author":"Xue","year":"2021","journal-title":"Br J Nutr"},{"key":"10.1016\/j.numecd.2025.104215_bib51","article-title":"Waist-to-height ratio is an effective indicator for comprehensive cardiovascular health","volume":"7","author":"Shen","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.numecd.2025.104215_bib52","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1253\/circj.CJ-12-0337","article-title":"The significance of measuring body fat percentage determined by bioelectrical impedance analysis for detecting subjects with cardiovascular disease risk factors","volume":"76","author":"Yamashita","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.numecd.2025.104215_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.1018460","article-title":"Association between sedentary behavior, physical activity, and cardiovascular disease-related outcomes in adults-A meta-analysis and systematic review","volume":"10","author":"Liang","year":"2022","journal-title":"Front Public Health"},{"key":"10.1016\/j.numecd.2025.104215_bib54","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/ajcn\/nqy097","article-title":"Dietary intake and blood concentrations of antioxidants and the risk of cardiovascular disease, total cancer, and all-cause mortality: a systematic review and dose-response meta-analysis of prospective studies","volume":"108","author":"Aune","year":"2018","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.numecd.2025.104215_bib55","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1093\/eurheartj\/ehi183","article-title":"Associations between cigarette smoking, pipe\/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease","volume":"26","author":"Wannamethee","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2025.104215_bib56","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1249\/JES.0000000000000027","article-title":"Stress, behavior, and biology: risk factors for cardiovascular diseases in youth","volume":"42","author":"Roemmich","year":"2014","journal-title":"Exerc Sport Sci Rev"},{"key":"10.1016\/j.numecd.2025.104215_bib57","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.numecd.2013.02.007","article-title":"Moderate alcohol use and health: a consensus document","volume":"23","author":"Poli","year":"2013","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2025.104215_bib58","doi-asserted-by":"crossref","unstructured":"Iatan I., Koschinsky M.L., Trenaman L., Zhang W., Thanassoulis G., Brunham L.R., et al. Rationale for the routine screening of lipoprotein (a) in cardiovascular risk assessment. Eur J Prev Cardiol 2025 in press.","DOI":"10.1093\/eurjpc\/zwaf342"},{"key":"10.1016\/j.numecd.2025.104215_bib59","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.athplu.2025.04.003","article-title":"Plasma apolipoprotein concentrations and occurrence of cardiovascular events in the general population: an exploratory analysis","volume":"60","author":"Torossian","year":"2025","journal-title":"Atheroscler Plus"},{"key":"10.1016\/j.numecd.2025.104215_bib60","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.3233\/THC-220874","article-title":"Triglyceride level as a potential marker of residual cardiovascular risk and its relation to HeartScore","volume":"31","author":"Ademovic","year":"2023","journal-title":"Technol Health Care"},{"key":"10.1016\/j.numecd.2025.104215_bib61","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/jcla.21977","article-title":"Detection of serum interleukin-6\/10\/18 levels in sepsis and its clinical significance","volume":"30","author":"Feng","year":"2016","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.numecd.2025.104215_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102956","article-title":"Effects of tumour necrosis factor on cardiovascular disease and cancer: a two-sample Mendelian randomization study","volume":"59","author":"Yuan","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.numecd.2025.104215_bib63","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1538-7836.2005.01678.x","article-title":"Soluble intracellular adhesion molecule-1 is associated with cardiovascular disease risk and mortality in older adults","volume":"4","author":"Jenny","year":"2006","journal-title":"J Thromb Haemostasis"},{"key":"10.1016\/j.numecd.2025.104215_bib64","article-title":"Myeloperoxidase as an active disease biomarker: recent biochemical and pathological perspectives","volume":"6","author":"Khan","year":"2018","journal-title":"Med Sci"},{"key":"10.1016\/j.numecd.2025.104215_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166170","article-title":"VCAM-1 as a predictor biomarker in cardiovascular disease","volume":"1867","author":"Troncoso","year":"2021","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.numecd.2025.104215_bib66","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12872-019-1068-5","article-title":"Serum ferritin, an early marker of cardiovascular risk: a study in Chinese men of first-degree relatives with family history of type 2 diabetes","volume":"19","author":"Liu","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.numecd.2025.104215_bib67","doi-asserted-by":"crossref","DOI":"10.1177\/03000605231164548","article-title":"Insulin resistance and cardiovascular disease","volume":"51","author":"Kosmas","year":"2023","journal-title":"J Int Med Res"},{"key":"10.1016\/j.numecd.2025.104215_bib68","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/bs.vh.2020.12.019","article-title":"Ghrelin and adipokines: an overview of their physiological role, antimicrobial activity and impact on cardiovascular conditions","volume":"115","author":"Perpetuo","year":"2021","journal-title":"Vitam Horm"},{"key":"10.1016\/j.numecd.2025.104215_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25042338","article-title":"Role of leptin in obesity, cardiovascular disease, and type 2 diabetes","volume":"25","author":"Vilarino-Garcia","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.numecd.2025.104215_bib70","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ahj.2012.03.023","article-title":"Fasting glucose levels within the high normal range predict cardiovascular outcome","volume":"164","author":"Shaye","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.numecd.2025.104215_bib71","doi-asserted-by":"crossref","first-page":"8037","DOI":"10.1038\/s41598-019-44430-w","article-title":"Author Correction: biomarkers of vascular injury in relation to myocardial infarction risk: a population-based study","volume":"9","author":"Pletsch-Borba","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.numecd.2025.104215_bib72","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1038\/s41598-018-38259-y","article-title":"Biomarkers of vascular injury in relation to myocardial infarction risk: a population-based study","volume":"9","author":"Pletsch-Borba","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.numecd.2025.104215_bib73","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.029110","article-title":"NT-proBNP and all-cause and cardiovascular mortality in us adults: a prospective cohort study","volume":"12","author":"Echouffo-Tcheugui","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.numecd.2025.104215_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/biom11081149","article-title":"Serum chemerin concentration is associated with proinflammatory status in chronic coronary syndrome","volume":"11","author":"Szpakowicz","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.numecd.2025.104215_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010193","article-title":"Fibrinogen and atherosclerotic cardiovascular diseases-review of the literature and clinical studies","volume":"23","author":"Surma","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.numecd.2025.104215_bib76","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1016\/j.ijcard.2013.07.088","article-title":"D-dimer: a novel predictive marker for cardiovascular disease","volume":"168","author":"Akgul","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.numecd.2025.104215_bib77","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1182\/blood-2014-08-528398","article-title":"Diagnostic approach to von Willebrand disease","volume":"125","author":"Ng","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.numecd.2025.104215_bib78","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.hipert.2022.08.001","article-title":"Carotid intima media thickness (CIMT) in adults in the AWI-Gen Nairobi site study: profiles and predictors","volume":"40","author":"Mohamed","year":"2023","journal-title":"Hipertens Riesgo Vasc"},{"key":"10.1016\/j.numecd.2025.104215_bib79","article-title":"An update on coronary artery calcium interpretation at chest and cardiac CT","volume":"3","author":"Obisesan","year":"2021","journal-title":"Radiol Cardiothorac Imag"},{"key":"10.1016\/j.numecd.2025.104215_bib80","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.atherosclerosis.2022.09.012","article-title":"The prevalence of cardiovascular disease is higher in patients with bilateral low ankle-brachial index than in patients with unilateral low ankle-brachial index","volume":"360","author":"Maruhashi","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2025.104215_bib81","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1016\/j.jacc.2021.04.052","article-title":"Systematic coronary risk evaluation (SCORE): JACC focus seminar 4\/8","volume":"77","author":"Graham","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2025.104215_bib82","first-page":"22","article-title":"Cardiovascular risk assessed by Reynolds risk score in relation to waist circumference in apparently healthy middle-aged population in Montenegro","volume":"57","author":"Klisic","year":"2018","journal-title":"Acta Clin Croat"},{"key":"10.1016\/j.numecd.2025.104215_bib83","article-title":"Rs10757274 gene polymorphisms in coronary artery disease: a systematic review and a meta-analysis","volume":"99","author":"Xu","year":"2020","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.numecd.2025.104215_bib84","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1161\/CIRCGENETICS.111.960146","article-title":"The coronary artery disease-associated 9p21 variant and later life 20-year survival to cohort extinction","volume":"4","author":"Dutta","year":"2011","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.numecd.2025.104215_bib85","article-title":"Association between genetic variants of CELSR2-PSRC1-SORT1 and cardiovascular diseases: a systematic review and meta-analysis","volume":"10","author":"Castillo-Avila","year":"2023","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/j.numecd.2025.104215_bib86","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.gene.2013.02.047","article-title":"Relationship between chemokine (C-X-C motif) ligand 12 gene variant (rs1746048) and coronary heart disease: case-control study and meta-analysis","volume":"521","author":"Huang","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.numecd.2025.104215_bib87","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.recesp.2014.10.023","article-title":"Association between coronary artery disease genetic variants and subclinical atherosclerosis: an association study and meta-analysis","volume":"68","author":"Zabalza","year":"2015","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.numecd.2025.104215_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11133798","article-title":"High-sensitivity cardiac troponin T and the diagnosis of cardiovascular disease in the emergency room: the importance of combining cardiovascular biomarkers with clinical data","volume":"11","author":"Golino","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.numecd.2025.104215_bib89","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024302","article-title":"Usefulness of B-type natriuretic peptide for predicting the risk of stroke in patients with heart failure with preserved ejection fraction","volume":"11","author":"Liu","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.numecd.2025.104215_bib90","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3892\/etm.2020.8840","article-title":"C-reactive protein and cardiovascular disease: from animal studies to the clinic","volume":"20","author":"Fu","year":"2020","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.numecd.2025.104215_bib91","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/01.ATV.0000163262.83456.6d","article-title":"Myeloperoxidase and cardiovascular disease","volume":"25","author":"Nicholls","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2025.104215_bib92","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-52082-z","article-title":"Trimethylamine-N-Oxide (TMAO) predicts cardiovascular mortality in peripheral artery disease","volume":"9","author":"Roncal","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.numecd.2025.104215_bib93","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00380-014-0473-z","article-title":"Impact of lysophosphatidylcholine on survival and function of UEA-1(+)acLDL (+) endothelial progenitor cells in patients with coronary artery disease","volume":"30","author":"Hong","year":"2015","journal-title":"Heart Vessel"},{"key":"10.1016\/j.numecd.2025.104215_bib94","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.freeradbiomed.2024.04.218","article-title":"Itaconate as a key player in cardiovascular immunometabolism","volume":"219","author":"Shan","year":"2024","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.numecd.2025.104215_bib95","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.atherosclerosis.2022.04.026","article-title":"Association of circulating branched-chain amino acids with risk of cardiovascular disease: a systematic review and meta-analysis","volume":"350","author":"Wang","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2025.104215_bib96","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s10020-018-0060-3","article-title":"The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review","volume":"24","author":"Fishman","year":"2018","journal-title":"Mol Med"},{"key":"10.1016\/j.numecd.2025.104215_bib97","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11090621","article-title":"Lipid metabolite biomarkers in cardiovascular disease: discovery and biomechanism translation from human studies","volume":"11","author":"McGranaghan","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.numecd.2025.104215_bib98","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.913429","article-title":"Corrigendum: miR-21 in human cardiomyopathies","volume":"9","author":"Surina","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.numecd.2025.104215_bib99","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.767064","article-title":"miR-21 in human cardiomyopathies","volume":"8","author":"Surina","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.numecd.2025.104215_bib100","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.2174\/0929867329666220830100530","article-title":"The role of MicroRNA-126 in atherosclerotic cardiovascular diseases","volume":"30","author":"Theofilis","year":"2023","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.numecd.2025.104215_bib101","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13148-023-01468-y","article-title":"DNA methylation and cardiovascular disease in humans: a systematic review and database of known CpG methylation sites","volume":"15","author":"Krolevets","year":"2023","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.numecd.2025.104215_bib102","article-title":"Histone methylation related therapeutic challenge in cardiovascular diseases","volume":"8","author":"Yang","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.numecd.2025.104215_bib103","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21062012","article-title":"Role of microRNAs in the development of cardiovascular disease in systemic autoimmune disorders","volume":"21","author":"Lopez-Pedrera","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.numecd.2025.104215_bib104","doi-asserted-by":"crossref","first-page":"8110","DOI":"10.18632\/aging.204311","article-title":"RNA modifications in aging-associated cardiovascular diseases","volume":"14","author":"Yang","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.numecd.2025.104215_bib105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24109087","article-title":"Gut microbiota and cardiovascular disease: evidence on the metabolic and inflammatory background of a complex relationship","volume":"24","author":"Nesci","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.numecd.2025.104215_bib106","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.849005","article-title":"Increased relative abundance of ruminoccocus is associated with reduced cardiovascular risk in an obese population","volume":"9","author":"Lakshmanan","year":"2022","journal-title":"Front Nutr"},{"key":"10.1016\/j.numecd.2025.104215_bib107","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/CIRCRESAHA.120.316242","article-title":"Gut microbiota and cardiovascular disease","volume":"127","author":"Witkowski","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.numecd.2025.104215_bib108","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S2213-8587(18)30037-8","article-title":"Precision nutrition for prevention and management of type 2 diabetes","volume":"6","author":"Wang","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.numecd.2025.104215_bib109","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.4103\/jpbs.jpbs_539_25","article-title":"Endocrine disorder: advance in understanding diabetes and obesity A review","volume":"17","author":"Salunke","year":"2025","journal-title":"J Pharm BioAllied Sci"},{"key":"10.1016\/j.numecd.2025.104215_bib110","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.cell.2014.11.034","article-title":"Metabolic inflexibility: when mitochondrial indecision leads to metabolic gridlock","volume":"159","author":"Muoio","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.numecd.2025.104215_bib111","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.freeradbiomed.2021.12.008","article-title":"Strategies to protect against age-related mitochondrial decay: do natural products and their derivatives help?","volume":"178","author":"Visioli","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.numecd.2025.104215_bib112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0355-7","article-title":"Mitochondrial dysfunction and oxidative stress in heart disease","volume":"51","author":"Peoples","year":"2019","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.numecd.2025.104215_bib113","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14113706","article-title":"Mitochondrial dysfunction in the development and progression of cardiometabolic diseases: a narrative review","volume":"14","author":"Pliouta","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.numecd.2025.104215_bib114","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3818196","article-title":"Advanced glycation end products (AGEs): biochemistry, signaling, analytical methods, and epigenetic effects","volume":"2020","author":"Perrone","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.numecd.2025.104215_bib115","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s12551-024-01188-4","article-title":"An overview on glycation: molecular mechanisms, impact on proteins, pathogenesis, and inhibition","volume":"16","author":"Uceda","year":"2024","journal-title":"Biophys Rev"},{"key":"10.1016\/j.numecd.2025.104215_bib116","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11886-022-01635-2","article-title":"Associations of glycemic index and glycemic load with cardiovascular disease: updated evidence from meta-analysis and cohort studies","volume":"24","author":"Dwivedi","year":"2022","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.numecd.2025.104215_bib117","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11906-023-01243-7","article-title":"Plant-based diets reduce blood pressure: a systematic review of recent evidence","volume":"25","author":"Tome-Carneiro","year":"2023","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.numecd.2025.104215_bib118","doi-asserted-by":"crossref","DOI":"10.3390\/biom14050559","article-title":"Biological rhythms, chrono-nutrition, and gut microbiota: epigenomics insights for precision nutrition and metabolic health","volume":"14","author":"de Oliveira Melo","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.numecd.2025.104215_bib119","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nature08778","article-title":"SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation","volume":"464","author":"Hirschey","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.numecd.2025.104215_bib120","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1093\/hmg\/ddu059","article-title":"Mitochondrial protein acetylation is driven by acetyl-CoA from fatty acid oxidation","volume":"23","author":"Pougovkina","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.numecd.2025.104215_bib121","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1419685","article-title":"The role of HDAC3 in inflammation: mechanisms and therapeutic implications","volume":"15","author":"Watson","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.numecd.2025.104215_bib122","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.672447","article-title":"The role of histone protein acetylation in regulating endothelial function","volume":"9","author":"Fang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.numecd.2025.104215_bib123","first-page":"315","article-title":"Precision nutrition based on phenotypical traits and the (epi)genotype: nutrigenetic and nutrigenomic approaches for obesity care","volume":"24","author":"Ramos-Lopez","year":"2021","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.numecd.2025.104215_bib124","first-page":"1","article-title":"Guidance and position of RINN22 regarding precision nutrition and nutriomics","volume":"18","author":"Ramos-Lopez","year":"2025","journal-title":"Lifestyle Genom"},{"key":"10.1016\/j.numecd.2025.104215_bib125","article-title":"Personalised nutrition and health","volume":"361","author":"Ordovas","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.numecd.2025.104215_bib126","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/s41591-024-03163-8","article-title":"What will it take to make precision health a global reality","volume":"30","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.numecd.2025.104215_bib127","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.cell.2015.11.001","article-title":"Personalized nutrition by prediction of glycemic responses","volume":"163","author":"Zeevi","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.numecd.2025.104215_bib128","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/S0140-6736(19)30041-8","article-title":"Health effects of dietary risks in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"393","author":"Collaborators","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.numecd.2025.104215_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.tifs.2022.10.010","article-title":"Reprint of: precision nutrition: a review of current approaches and future endeavors","volume":"130","author":"Livingstone","year":"2022","journal-title":"Trends Food Sci Technol"},{"key":"10.1016\/j.numecd.2025.104215_bib130","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1056\/NEJMra1105239","article-title":"Genomics of cardiovascular disease","volume":"365","author":"O'Donnell","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2025.104215_bib131","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028022","article-title":"Metabolomic profiles, ideal cardiovascular health, and risk of heart failure and atrial fibrillation: insights from the framingham heart study","volume":"12","author":"Li","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.numecd.2025.104215_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.117877","article-title":"Proteomics in cardiovascular disease","volume":"557","author":"Gong","year":"2024","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.numecd.2025.104215_bib133","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.903570","article-title":"The gut microbiota (microbiome) in cardiovascular disease and its therapeutic regulation","volume":"12","author":"Rahman","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.numecd.2025.104215_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104952","article-title":"Microbiota and cardiovascular disease risk: a scoping review","volume":"159","author":"Scarmozzino","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.numecd.2025.104215_bib135","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab061","article-title":"Multi-omics approaches for revealing the complexity of cardiovascular disease","volume":"22","author":"Doran","year":"2021","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.numecd.2025.104215_bib136","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/bs.pmbts.2022.03.002","article-title":"Artificial intelligence and machine learning in precision medicine: a paradigm shift in big data analysis","volume":"190","author":"Sahu","year":"2022","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/j.numecd.2025.104215_bib137","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1139\/gen-2020-0131","article-title":"Machine learning for precision medicine","volume":"64","author":"MacEachern","year":"2021","journal-title":"Genome"},{"key":"10.1016\/j.numecd.2025.104215_bib138","article-title":"Cardiovascular risks associated with gender and aging","volume":"6","author":"Rodgers","year":"2019","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/j.numecd.2025.104215_bib139","doi-asserted-by":"crossref","DOI":"10.3945\/an.113.005389","article-title":"Mediterranean diet and cardiovascular health: teachings of the PREDIMED study","volume":"5","author":"Ros","year":"2014","journal-title":"Adv Nutr"},{"key":"10.1016\/j.numecd.2025.104215_bib140","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0140-6736(22)00122-2","article-title":"Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial","volume":"399","author":"Delgado-Lista","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.numecd.2025.104215_bib141","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.nutres.2024.03.007","article-title":"Fostering wellbeing and healthy lifestyles through conviviality and commensality: underappreciated benefits of the Mediterranean Diet","volume":"126","author":"Bernardi","year":"2024","journal-title":"Nutr Res"},{"key":"10.1016\/j.numecd.2025.104215_bib142","doi-asserted-by":"crossref","unstructured":"Seth C., Schmid V., Mueller S., Haykowsky M., Foulkes S.J., Halle M., et al. Diabetes, obesity, and cardiovascular disease-what is the impact of lifestyle modification? Herz 2025. in press.","DOI":"10.1007\/s00059-025-05316-y"},{"key":"10.1016\/j.numecd.2025.104215_bib143","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu12123782","article-title":"Fatty acids and cardiovascular risk. Evidence, lack of evidence, and diligence","volume":"12","author":"Visioli","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.numecd.2025.104215_bib144","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1006\/phrs.1999.0650","article-title":"Very low intakes of n-3 fatty acids incorporated into bovine milk reduce plasma triacylglycerol and increase HDL-cholesterol concentrations in healthy subjects","volume":"41","author":"Visioli","year":"2000","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.numecd.2025.104215_bib145","article-title":"Interaction between non-alcoholic fatty liver disease and obesity on the risk of developing cardiovascular diseases","volume":"14","author":"Wang","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.numecd.2025.104215_bib146","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1136\/gutjnl-2021-325724","article-title":"Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort","volume":"71","author":"Simon","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.numecd.2025.104215_bib147","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9869208","article-title":"The emerging role of MicroRNA-155 in cardiovascular diseases","volume":"2016","author":"Cao","year":"2016","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.numecd.2025.104215_bib148","doi-asserted-by":"crossref","DOI":"10.3390\/nu13082679","article-title":"Gut microbiota and subclinical cardiovascular disease in patients with type 2 diabetes mellitus","volume":"13","author":"Tsai","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.numecd.2025.104215_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.phanu.2023.100367","article-title":"The effect of supplementation with a multi-species synbiotic on serum lipid profile, abundance of beneficial gut bacteria and firmicutes to bacteroidetes ratio in patients with dyslipidemia; a randomized, double-blind, placebo-controlled, clinical trial","volume":"27","author":"Salamat","year":"2024","journal-title":"PharmaNutrition"},{"key":"10.1016\/j.numecd.2025.104215_bib150","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1016\/j.cell.2025.04.016","article-title":"The microbiome for clinicians","volume":"188","author":"Porcari","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.numecd.2025.104215_bib151","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1210\/jc.2003-030636","article-title":"Clinical review 163: cardiovascular endocrinology: low-density lipoprotein size and cardiovascular disease: a reappraisal","volume":"88","author":"Sacks","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2025.104215_bib152","first-page":"2499","article-title":"Lipid-related markers and cardiovascular disease prediction","volume":"307","author":"Emerging Risk Factors","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2025.104215_bib153","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jacc.2018.10.072","article-title":"Cholesteryl ester transfer protein inhibition for preventing cardiovascular events: JACC review topic of the week","volume":"73","author":"Armitage","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2025.104215_bib154","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1161\/01.ATV.0000222983.73369.c8","article-title":"Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function, and hemodynamic stress","volume":"26","author":"Koenig","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2025.104215_bib155","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1273042","article-title":"Small dense low-density lipoprotein as biomarker for atherosclerotic diseases","volume":"2017","author":"Ivanova","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.numecd.2025.104215_bib156","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8091357","article-title":"Low serum paraoxonase-1 activity associates with incident cardiovascular disease risk in subjects with concurrently high levels of high-density lipoprotein cholesterol and C-reactive protein","volume":"8","author":"Corsetti","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.numecd.2025.104215_bib157","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bbadis.2005.09.002","article-title":"Phospholipid transfer protein activity is associated with inflammatory markers in patients with cardiovascular disease","volume":"1762","author":"Cheung","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.numecd.2025.104215_bib158","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24086956","article-title":"Untargeted lipidomic profiling reveals lysophosphatidylcholine and ceramide as atherosclerotic risk factors in apolipoprotein E knockout mice","volume":"24","author":"Law","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.numecd.2025.104215_bib159","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24031966","article-title":"PCSK9 as an atherothrombotic risk factor","volume":"24","author":"Sotler","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.numecd.2025.104215_bib160","first-page":"439","article-title":"High-sensitivity C-reactive protein: clinical importance","volume":"29","author":"Bassuk","year":"2004","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.numecd.2025.104215_bib161","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1373\/clinchem.2018.297242","article-title":"Iron metabolism, hepcidin, and mortality (the ludwigshafen risk and cardiovascular health study)","volume":"65","author":"Grammer","year":"2019","journal-title":"Clin Chem"},{"key":"10.1016\/j.numecd.2025.104215_bib162","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jacc.2016.05.092","article-title":"Cystatin C and cardiovascular disease: a mendelian randomization study","volume":"68","author":"van der Laan","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2025.104215_bib163","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3892\/etm.2021.10996","article-title":"Insulin resistance quantified by the value of HOMA-IR and cardiovascular risk in patients with type 2 diabetes","volume":"23","author":"Vladu","year":"2022","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.numecd.2025.104215_bib164","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12933-022-01511-x","article-title":"Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations","volume":"21","author":"Tao","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.numecd.2025.104215_bib165","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.arcmed.2019.08.009","article-title":"Atherogenic index of plasma: novel predictive biomarker for cardiovascular illnesses","volume":"50","author":"Fernandez-Macias","year":"2019","journal-title":"Arch Med Res"},{"key":"10.1016\/j.numecd.2025.104215_bib166","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1055\/s-0042-1744240","article-title":"Assessment of dyslipidemia, lipid ratios, and atherogenic indices as cardiovascular risk factors in prediabetic and diabetic subjects","volume":"14","author":"Rathi","year":"2022","journal-title":"J Lab Physicians"},{"key":"10.1016\/j.numecd.2025.104215_bib167","article-title":"The triglyceride\/high-density lipoprotein cholesterol (TG\/HDL-C) ratio as a risk marker for metabolic syndrome and cardiovascular disease","volume":"13","author":"Kosmas","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.numecd.2025.104215_bib168","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2796.2006.01643.x","article-title":"The apoB\/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence","volume":"259","author":"Walldius","year":"2006","journal-title":"J Intern Med"},{"key":"10.1016\/j.numecd.2025.104215_bib169","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/gutjnl-2023-331003","article-title":"Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease","volume":"73","author":"Lee","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.numecd.2025.104215_bib170","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12902-023-01372-9","article-title":"The Association between Cardio-metabolic and hepatic indices and anthropometric measures with metabolically obesity phenotypes: a cross-sectional study from the Hoveyzeh Cohort Study","volume":"23","author":"Zakerkish","year":"2023","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.numecd.2025.104215_bib171","first-page":"8598","article-title":"Homocysteine as a predictor and prognostic marker of atherosclerotic cardiovascular disease: a systematic review and meta-analysis","volume":"27","author":"Habib","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.numecd.2025.104215_bib172","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010287","article-title":"The role of haptoglobin polymorphism in cardiovascular disease in the setting of diabetes","volume":"22","author":"Somer","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.numecd.2025.104215_bib173","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/157340310791162659","article-title":"The role of asymmetric dimethylarginine (ADMA) in endothelial dysfunction and cardiovascular disease","volume":"6","author":"Sibal","year":"2010","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.numecd.2025.104215_bib174","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014070","article-title":"Fatty acid binding protein-4 and risk of cardiovascular disease: the cardiovascular health study","volume":"9","author":"Egbuche","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.numecd.2025.104215_bib175","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2217\/bmm-2020-0776","article-title":"Sialic acid as a potential biomarker for cardiovascular disease, diabetes and cancer","volume":"15","author":"Cheeseman","year":"2021","journal-title":"Biomark Med"},{"key":"10.1016\/j.numecd.2025.104215_bib176","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/ajh\/hpt232","article-title":"Circulating des-acyl ghrelin improves cardiovascular risk prediction in older hypertensive patients","volume":"27","author":"Yano","year":"2014","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.numecd.2025.104215_bib177","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/eurjpc\/zwad318","article-title":"Validation of systematic coronary risk evaluation 2 (SCORE2) and SCORE2-older persons in the EPIC-norfolk prospective population cohort","volume":"31","author":"van Trier","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.numecd.2025.104215_bib178","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4162\/nrp.2012.6.3.246","article-title":"The framingham risk score, diet, and inflammatory markers in Korean men with metabolic syndrome","volume":"6","author":"Sohn","year":"2012","journal-title":"Nutr Res Prac"},{"key":"10.1016\/j.numecd.2025.104215_bib179","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.recesp.2010.11.006","article-title":"[Clinical applicability of the framingham 30-year risk score. Usefulness in cardiovascular risk stratification and the diagnosis of carotid atherosclerotic plaque]","volume":"64","author":"Masson","year":"2011","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.numecd.2025.104215_bib180","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1157\/13099460","article-title":"[Comparison of the REGICOR and SCORE function charts for classifying cardiovascular risk and for selecting patients for hypolipidemic or antihypertensive treatment]","volume":"60","author":"Buitrago","year":"2007","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.numecd.2025.104215_bib181","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2023.131120","article-title":"Predictive value of ASCVD risk score for mortality and major adverse cardiovascular events in the year following a COVID-19 infection among US Veterans","volume":"387","author":"Guardino","year":"2023","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.numecd.2025.104215_bib182","first-page":"613","article-title":"The new pooled cohort equations risk calculator","volume":"31","author":"Preiss","year":"2015","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.numecd.2025.104215_bib183","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-71140-5","article-title":"Assessment of predictive validity and feasibility of Edmonton Frail Scale in identifying postoperative complications among elderly patients: a prospective observational study","volume":"10","author":"He","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.numecd.2025.104215_bib184","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.8232","article-title":"Evaluating Cardiovascular Disease (CVD) risk scores for participants with known CVD and non-CVD in a multiracial\/ethnic Caribbean sample","volume":"8","author":"Hosein","year":"2020","journal-title":"PeerJ"},{"key":"10.1016\/j.numecd.2025.104215_bib185","article-title":"Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study","volume":"357","author":"Hippisley-Cox","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.numecd.2025.104215_bib186","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1177\/1741826710389925","article-title":"CUORE project: implementation of the 10-year risk score","volume":"18","author":"Palmieri","year":"2011","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.numecd.2025.104215_bib187","first-page":"43","article-title":"Cardiovascular risk assessment in HIV-infected male patients: a comparison of Framingham, SCORE, PROCAM and DAD risk equations","volume":"23","author":"Pirs","year":"2014","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"10.1016\/j.numecd.2025.104215_bib188","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252212017","article-title":"Vascular extracellular Matrix in atherosclerosis","volume":"25","author":"Di Nubila","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.numecd.2025.104215_bib189","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2400675121","article-title":"The IRG1-itaconate axis protects from cholesterol-induced inflammation and atherosclerosis","volume":"121","author":"Cyr","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.numecd.2025.104215_bib190","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.773314","article-title":"miR-208a in cardiac hypertrophy and remodeling","volume":"8","author":"Huang","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.numecd.2025.104215_bib191","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/HCO.0000000000001041","article-title":"Long noncoding RNAs in cardiovascular disease","volume":"38","author":"Kohlmaier","year":"2023","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.numecd.2025.104215_bib192","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1161\/CIRCRESAHA.116.309219","article-title":"Gut microbiome associates with lifetime cardiovascular disease risk profile among bogalusa heart study participants","volume":"119","author":"Kelly","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.numecd.2025.104215_bib193","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/ajcn\/76.6.1249","article-title":"Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers","volume":"76","author":"Naruszewicz","year":"2002","journal-title":"Am J Clin Nutr"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475325003692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475325003692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:59:45Z","timestamp":1763600385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475325003692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":193,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0939475325003692"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2025.104215","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Translational biomarkers for integrated cardiovascular disease risk assessment: A multidisciplinary review with applications in precision medicine","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2025.104215","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104215"}}